Gerresheimer could make an acquisition for EUR 200m-EUR 300m
Gerresheimer, the listed German pharmaceutical packaging maker, could make an acquisition for EUR 200m-EUR 300m, Chief Executive Uwe Roeheroff told Boersen-Zeitung.
During a conversation with the German-language daily, Roeheroff said that acquisition targets would need to be a good fit and would need to fulfill certain criteria. He said the company will not buy problematic companies or ones that need restructuring.
Small acquisitions may happen in emerging markets, he said. He added that Gerresheimer may use acquisitions to boost its business offering medical devices in North America, and is closely examining the US market.
He also confirmed that Gerresheimer's 51% stake in its life science joint venture with Thermo Fisher may be sold. He said the business is profitable but has few synergies with Gerresheimer's other activities. He said that while attractive offers will be considered, Gerresheimer is not actively pushing for a sale.
Source Boersen-Zeitung